Mark Choquette, MD
Emergency Medicine · Dothan, ALNPI 1992777619
Payments from drug & device makers
Across 21 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$98
- Boehringer Ingelheim$73
- Pacira Therapeutics, Inc.$65
- Pacira Pharmaceuticals Incorporated$25
- Verona Pharma, Inc.$24
- Vertex$23
- plus $111 from 7 others
What the payments were for
- Food & beverage$420100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 1 | $98 |
| Boehringer Ingelheim | 6 | $73 |
| Pacira Therapeutics, Inc. | 4 | $65 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Verona Pharma, Inc. | 1 | $24 |
| Vertex | 1 | $23 |
| Amgen | 1 | $20 |
| Pfizer | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| GSK | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Bioventus LLC | 1 | $12 |
How this compares
$420 in reported general payments places this provider in the 85th percentile of 565 emergency medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 82 | $8,236 |
| Tizanidine Hcl | 412 | $4,519 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $2,995 |
| Meloxicam | 697 | $1,915 |
| Methocarbamol | 95 | $1,699 |
| Celecoxib | 143 | $1,662 |
| Buprenorphine Hcl | 64 | $1,646 |
| Duloxetine Hcl | 23 | $890 |
| Tramadol Hcl | 242 | $829 |
| Probenecid-ColchicineProbenecid/Colchicine | 18 | $772 |
| Gabapentin | 46 | $497 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $419 |
| Oxybutynin Chloride ErOxybutynin Chloride | 12 | $368 |
| Cyclobenzaprine Hcl | 35 | $360 |
| Naproxen | 21 | $275 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Dothan
- Mathew KristaDothan$2K
- John McDonaldDothan$1K
- Steven OmaraMontgomery$2.1M
- Jason BegueBirmingham$1M
- Mark MitchellAtmore$309K
- James GalbraithBirmingham$188K
- Norman GarrisonMontgomery$69K
- Lauren WalterBirmingham$64K
- Mark ChristensenBoaz$31K
- Ziad KazziBirmingham$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.